Editorial by #EugeneBraunwald : Advances in the treatment of #HCM Timeline for hypertrophic cardiomyopathy (HCM) treatment and future directions @ESC_Journals #EHJ

RT @crfheart: 🚀 #THT2025 kicks off this Tuesday! 🚀 It’s time to gear up for groundbreaking data and the latest updates on #heartfailure.…

RT @NIH: Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead,…

RT @TCTMD: Jennifer Rymer (@jennifer_rymer) and Srihari Naidu (@SrihariNaiduMD) discuss the @JCardFail edition they recently edited, which…

The vicious circle of #anaemia, neurohormonal activation, and myocardial #iron depletion in heart failure #EHJ @ehj_ed

RT @ESC_Journals: Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF…

RT @TCTMD: CVD Hospitalization in Older Adults Higher in US Than in Denmark

RT @HanCardiomd: #THT2025 is around the corner! Don’t miss your chance to register and join the on-site learning on heart failure treatme…

#THT2025 is around the corner! Don’t miss your chance to register and join the on-site learning on heart failure treatment updates. This meeting will foster networking and drive new innovations in the latest heart failure care medicine and treatment. @crfheart @TCTMD @JavedButler1 @AndrewJSauer @ShelleyZieroth #HeartFailure #THT2025

RT @crfheart: ✨ In just four years, THT has transformed into the premier conference for #heartfailure innovation. Join Dr. Ulrich P. Jorde…

RT @mvaduganathan: 🔥#CONFIDENCE, the largest trial of combination #SGLT2i + #MRA (versus either alone) in #CKD and #T2D, is fully recruited…

RT @TCTMD: Propranolol Linked to Stroke Protection in Women With Migraine

Personalized therapeutic vaccine ‘steers’ the immune system to fight kidney cancer Such a great news of the year ! @YaleMed @BraunMDPhD @jennkwanMDPhD #PhysicianScientists @AJIAorg

RT @jennkwanMDPhD: Congrats @BraunMDPhD! “Developing a steering wheel for immunotherapy” as you would say #physicianscientist

RT @EHJCVIEiC: #EHJCVI % voted leiomyomatosis which is the ✅ correct answer ✨ 🔑 It is a rare tumor forming multiple thrombi 🏥 It follows a…

RT @AndrewJSauer: 🚨 Obesity-Related Heart Failure! 🚨 A FINEARTS analysis in JACC highlights promising treatments for HFpEF in people with…

RT @matslassen: Our new study on CV hosp rates among elderly in the US 🇺🇸 compared to DK 🇩🇰 is now out in @JAMACardio 🎉 - CV hosp rate 1.5…

RT @FraSantoroMD: Our Manuscript out in @JACCJournals HF!! Beta-blockers could have some potential survival benefit in Takotsubo Syndrome!…

Beta-Blockers and Long-Term Mortality in #Takotsubo Syndrome #GEIST Registry Study on Beta-Blockers in TTS 📊 N= 2,853 patients with Takotsubo syndrome (TTS) 💊 Beta-blockers at discharge (74.5%) linked to lower mortality (HR: 0.71, 95% CI: 0.55-0.90), especially in year 1 📌No impact on TTS recurrence (HR: 0.74, 95% CI: 0.61-1.89) or #LVEF recovery @JACCJournals @S_Raposeiras

RT @ESC_Journals: 🚨 #FAIRHF2: double-blind RCT w 1105 pts with #HFrEF & iron deficiency. Over ≥2 y, pts receive placebo-controlled IV iron.…